<DOC>
	<DOCNO>NCT00688376</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety tolerability donepezil child persistent attention impairment present least 12 month completion cancer treatment .</brief_summary>
	<brief_title>Efficacy Safety Donepezil Hydrochloride Preadolescent Adolescent Children With Attention Impairment Following Cancer Treatment</brief_title>
	<detailed_description>This double-blind , placebo-controlled , parallel group study pediatric subject persistent attention impairment follow treatment cancer . This trial three phase : ( 1 ) pre-randomization establish eligibility , ( 2 ) 12-week , double-blind , placebo-controlled , parallel-group phase dose escalation base body weight , ( 3 ) 12-week , blind extension phase subject receive active drug .</detailed_description>
	<mesh_term>Donepezil</mesh_term>
	<criteria>1 . The subject must receive least one cycle chemotherapy and/or cranial radiation , must complete treatment least one year screen take place entry study . 2 . Subjects may male female ; age range : 6 17.5 year ; weight ≥ 20 kg . They must physically healthy able move , without aid , must live community , must adequate motor skill show test give time screen . The subject 's eyesight hearing must good enough allow cooperation test physical examination . Additionally , must able swallow tablet . 3 . There must subjective complaint subject and/or parent difficulty school daily activity , possibly related impairment attention . These difficulty must emerge treatment cancer must still present 12 month cessation treatment . There must also objective evidence impairment , show test give subject time screening . 4 . The IQ must &gt; 70 accord test give time screen . 5 . The first language subject learn read write must one use Roman lettering ( , b , c , etc . ) Arabic numeral ( 1 , 2 , 3 , etc. ) . 6 . The subject must previously take drug class know cholinesterase inhibitor . 7 . A parent legal guardian must available willing able complete outcome measure , administer medication , accompany subject require clinic visit . 8 . Subjects diabetes thyroid disease may still eligible certain medical requirement satisfy . 9 . Female subject could become pregnant must undergo pregnancy test must agree use contraception . Subjects meet follow criterion exclude study : 1 . Inability perform require test ( example , aphasia , motor deficit affect dominant hand , mental retardation ) . 2 . Motor coordination sufficient , accord test conduct time screen . 3 . Recurrence cancer . If happens , subject withdraw study . 4 . Mental retardation/developmental disability . 5 . Certain medication , methylphenidate , allow study . 6 . Major depression . 7 . Problems digestive tract could affect subject 's ability absorb study drug . 8 . Hypersensitivity chemical class know piperidine derivative . 9 . Certain medical condition determine clinical staff . 10 . Alcoholism , drug abuse , organic brain disease cause cancer treatment . 11 . Pregnancy , nursing , unwillingness undergo pregnancy test request clinical staff . 12 . Pregnancy , lactation plan become pregnant , unwilling take screen Betahuman chorionic gonadotropin ( ßhCG ) test female &gt; 10 year age . 13 . If sexually active , unwillingness use birth control ( male female ) . 14 . Plans certain type elective surgery would occur study progress . 15 . Plans travel event would interfere study schedule . 16 . Active treatment another investigational drug within 3 month screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Attention</keyword>
	<keyword>cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>donepezil</keyword>
	<keyword>acetylcholinesterase</keyword>
	<keyword>inhibitor</keyword>
</DOC>